Showing session: reset
Impact of a Brexit on Oncology Drug Development and Regulation
- Sort by:
- Browse by:
- Free
- slides video
- audio + slides
- All slides included
Introduction
Richard M. Marais
Cancer Research UK Manchester Inst., Manchester, United Kingdom
- Free
- audio + slides
- All slides included
Invited Speaker
John S Haurum
Cambridge, United Kingdom
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Susan M. Galbraith
AstraZeneca, Cambridge, United Kingdom
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Joanne M. Hackett
Genomics England, London, United Kingdom
- Free
- slides video
- audio + slides
- All slides included
Wrap-up
C. Simone Fishburn
BioCentury, Inc., Redwood City, CA, United States
- Free
- audio + slides
- All slides included
Panel Discussion
C. Simone Fishburn
BioCentury, Inc., Redwood City, CA, United States
Richard M. Marais
Cancer Research UK Manchester Inst., Manchester, United Kingdom
John S Haurum
Cambridge, United Kingdom
Susan M. Galbraith
AstraZeneca, Cambridge, United Kingdom
Joanne M. Hackett
Genomics England, London, United Kingdom